Preterm infants are susceptible to hyperglycemia and hypoglycemia, conditions which may lead to adverse neurodevelopment. The use of continuous glucose monitoring devices (CGM) might help keeping glucose levels in the normal range, and reduce the need for blood sampling. However, the use of CGM might be associated with harms in the preterm infant.
Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants
Galderisi, Alfonso;Trevisanuto, Daniele
2020
Abstract
Preterm infants are susceptible to hyperglycemia and hypoglycemia, conditions which may lead to adverse neurodevelopment. The use of continuous glucose monitoring devices (CGM) might help keeping glucose levels in the normal range, and reduce the need for blood sampling. However, the use of CGM might be associated with harms in the preterm infant.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Cochrane_Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Accesso gratuito
Dimensione
530.52 kB
Formato
Adobe PDF
|
530.52 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
